Announced Fri, 30 May · 18:34 IST

Submission of Audited Financial Results for the quarter and year ended 31st March, 2025

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nexus Surgical and Medicare reported strong FY25 results with total income of Rs. 572.83 lakhs, up about 64% from Rs. 350.11 lakhs in FY24. Profit before tax nearly doubled to Rs. 66.79 lakhs from Rs. 29.07 lakhs, while profit after tax jumped to Rs. 49.74 lakhs from Rs. 21.33 lakhs — a rise of over 130%. Q4 FY25 was also strong with total income of Rs. 148.92 lakhs versus Rs. 59.33 lakhs a year earlier. The auditor issued an unqualified (unmodified) opinion, and the company swung its operating cash flow back into positive territory at Rs. 10.42 lakhs compared with a Rs. 41.40 lakh outflow in FY24.

Likely market impact

Positive for shareholders — sharp revenue and profit growth, improving margins, and a turnaround in operating cash flow signal healthier business momentum. However, the company still carries negative other equity (reserves of Rs. -440.83 lakhs), which is a lingering concern despite the improved profitability.